Investment Thesis
Backing exceptional science with disciplined VC capital to build and scale European biopharma companies with real impact, focusing on robust preclinical validation and translational strategies.
Stage Focus
Early-stage to clinical-stage
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Science-driven innovations addressing unmet medical needs in biopharma
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
N/A
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
Investment Team (8)
C
Cees Stouten
Senior Drug Development & Manufacturing Expert
F
Frans van Dalen
Founding Partner
F
Frans van Dalen, Pharm.D.
Founding Partner
G
Gerjan Kemperman
Advisory Council Member
P
Paul Lelieveld
Co-Founder
P
Paul Lelieveld, Ir., MSc.
Founding Partner
P
Peter Goedings
Senior Clinical Expert
P
Ping Cao
Advisory Council Member
